MétaCan
Menu
Back to cohort
Record W2948733916 · doi:10.1158/2326-6066.cir-18-0891

Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth

2019· article· en· W2948733916 on OpenAlexfundno aff
Lubka T. Roumenina, Marie V. Daugan, Rémi Noé, Florent Petitprez, Yann Vano, Rafael Sanchez‐Salas, Étienne Becht, Julie Meilleroux, Bénédicte Le Clec'h, Nicolás A. Giraldo, Nicolas S. Merle, Cheng‐Ming Sun, Virginie Verkarre, Pierre Validire, Janick Sèlves, Laetitia Lacroix, Olivier Delfour, Isabelle Vandenberghe, Céline Thuilliez, Sonia Keddani, Imene B. Sakhi, Éric Barret, Pierre Ferré, Nathalie Corvaı̈a, A. Passioukov, Eric Chetaille, Marina Botto, Aurélien de Reyniès, Stéphane Oudard, Arnaud Méjean, Xavier Cathelineau, Catherine Sautès‐Fridman

Bibliographic record

VenueCancer Immunology Research · 2019
Typearticle
Languageen
FieldImmunology and Microbiology
TopicComplement system in diseases
Canadian institutionsnot available
FundersLabex Immuno-OncologySorbonne UniversitéInstitut National de la Santé et de la Recherche MédicaleLigue Contre le CancerLes Laboratories Pierre FabreInstitute of Cancer ResearchInstitut National Du CancerAssociation pour la Recherche sur le Cancer
KeywordsComplement systemTumor microenvironmentCancer researchImmune systemTumor progressionInflammationCancerBiologyImmunotherapyClear cell renal cell carcinomaAlternative complement pathwayImmunologyMedicineRenal cell carcinomaPathology

Abstract

fetched live from OpenAlex

Abstract Clear-cell renal cell carcinoma (ccRCC) possesses an unmet medical need, particularly at the metastatic stage, when surgery is ineffective. Complement is a key factor in tissue inflammation, favoring cancer progression through the production of complement component 5a (C5a). However, the activation pathways that generate C5a in tumors remain obscure. By data mining, we identified ccRCC as a cancer type expressing concomitantly high expression of the components that are part of the classical complement pathway. To understand how the complement cascade is activated in ccRCC and impacts patients' clinical outcome, primary tumors from three patient cohorts (n = 106, 154, and 43), ccRCC cell lines, and tumor models in complement-deficient mice were used. High densities of cells producing classical complement pathway components C1q and C4 and the presence of C4 activation fragment deposits in primary tumors correlated with poor prognosis. The in situ orchestrated production of C1q by tumor-associated macrophages (TAM) and C1r, C1s, C4, and C3 by tumor cells associated with IgG deposits, led to C1 complex assembly, and complement activation. Accordingly, mice deficient in C1q, C4, or C3 displayed decreased tumor growth. However, the ccRCC tumors infiltrated with high densities of C1q-producing TAMs exhibited an immunosuppressed microenvironment, characterized by high expression of immune checkpoints (i.e., PD-1, Lag-3, PD-L1, and PD-L2). Our data have identified the classical complement pathway as a key inflammatory mechanism activated by the cooperation between tumor cells and TAMs, favoring cancer progression, and highlight potential therapeutic targets to restore an efficient immune reaction to cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.362
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations274
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueCancer Immunology ResearchSame topicComplement system in diseasesFrench-language works237,207